The Cancer News

Adjuvant Ribociclib and Endocrine Therapy in Patients with HR+/HER2 Negative Early Breast Cancer: Phase III NATALEE Trial

By Editorial Team

By Dr. Shipra Gandhi from Roswell Park Comprehensive Cancer Center   Findings from the MonarchE clinical trial1 led to the approval of combination abemaciclib with AI in the adjuvant setting for pat...

A Summary of the DACOTA Trial

By Editorial Team

By Dr. Chepsy Philip [Believer's Church Medical College Hospital](https://www.bcmch.org/)   Myeloproliferative - Chronic Myelomonocytic Leukemia (MP-CMML), a subset in the rare patient population of C...

AEGEAN trial: A phase 3 study of Neoadjuvant Durvalumab plus Chemotherapy followed by Adjuvant Durvalumab versus Neoadjuvant Chemotherapy in Patients with Resectable Non-Small Cell Lung Cancer

By Editorial Team

By Dr. Dipesh Uprety [Karmanos Cancer Institute](https://www.karmanos.org/karmanos/karmanos-home)   Four cycles of cisplatin-based adjuvant chemotherapy after surgical resection have remained the stan...

Zuma 7 trial shows statistically significant overall survival benefit for yescarta

By Editorial Team

By Dr. Luke Fletcher [Willamette Valley Cancer Institute & Research Center](https://www.oregoncancer.com/) _The Zuma 7 trial is a randomized, open-label multicenter study for patients with primary ref...

2022 Updates in Lung Cancer Treatment

By Editorial Team

2023 Summit on Cancer Health Disparities (SCHD)

By Editorial Team

AGILE trial—Ivosidenib plus Azacitidine versus Azacitidine in IDH1 Mutated Acute Myeloid Leukemia

By Binaytara Team

Dr. Aditi Sharma of [Barbara Ann Karmanos Cancer Institute](https://www.karmanos.org/karmanos/karmanos-home) & Dr. Abhishek Mangaonkar of [Mayo Clinic](https://www.mayoclinic.org/)   In the phase III ...

Announcing Binaytara's 2023 Summit on Cancer Health Disparities (SCHD23)

By Editorial Team

The conference will be held at the Grand Hyatt in Seattle on April 28-30, 2023 ------------------------------------------------------------------------------ We invite you to attend the 2023 Summit o...

Volunteer Spotlight: June Zhu

By The Cancer News Team

Zhu Shares About Her Experience Volunteering at Binaytara

Binaytara Foundation Announces Dr. Umang Swami as Editor-in-Chief of the International Journal of Cancer Care & Delivery (IJCCD)

By Editorial Team

Swami Envisions the IJCCD as a Leading Journal in Cancer Health Disparities --------------------------------------------------------------------------- The Binaytara Foundation has named Dr. Umang Sw...